Federated Hermes’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,141	Closed	-$15.8K	–	2065
2025 Q3	$15.8K	Sell	3,141 -49,859	-94%	-$220K	﹤0.01%	1834
2025 Q2	$182K	Sell	53,000 -894,751	-94%	-$2.23M	﹤0.01%	1510
2025 Q1	$2.11M	Buy	947,751 +31,514	+3%	+$90.4K	﹤0.01%	919
2024 Q4	$2.68M	Sell	916,237 -1,366,459	-60%	-$3.81M	0.01%	866
2024 Q3	$5.94M	Sell	2,282,696 -443,320	-16%	-$1.23M	0.01%	685
2024 Q2	$8.07M	Sell	2,726,016 -89,443	-3%	-$338K	0.02%	599
2024 Q1	$12.8M	Sell	2,815,459 -302,221	-10%	-$1.54M	0.03%	521
2023 Q4	$17.8M	Sell	3,117,680 -136,673	-4%	-$633K	0.04%	417
2023 Q3	$15M	Sell	3,254,353 -119,702	-4%	-$728K	0.04%	437
2023 Q2	$21.8M	Buy	3,374,055 +469,796	+16%	+$3.21M	0.05%	359
2023 Q1	$21.9M	Buy	2,904,259 +381,937	+15%	+$3.47M	0.06%	368
2022 Q4	$25.6M	Buy	2,522,322 +418,281	+20%	+$4.83M	0.07%	327
2022 Q3	$20.8M	Buy	2,104,041 +367,822	+21%	+$4.04M	0.06%	372
2022 Q2	$18.5M	Buy	1,736,219 +448,219	+35%	+$3.8M	0.05%	405
2022 Q1	$12.6M	Buy	1,288,000 +460,153	+56%	+$4.36M	0.03%	547
2021 Q4	$11.8M	Buy	827,847 +237,847	+40%	+$3.61M	0.02%	603
2021 Q3	$11.8M	Buy	590,000 +194,000	+49%	+$3.43M	0.02%	604
2021 Q2	$8.71M	Buy	396,000 +346,000	+692%	+$9.54M	0.02%	704
2021 Q1	$1.7M	Hold	50,000	–	–	﹤0.01%	1164
2020 Q4	$2.01M	Buy	+50,000	New	+$2.29M	﹤0.01%	1062